Frederick Raal to Apolipoprotein A-I
This is a "connection" page, showing publications Frederick Raal has written about Apolipoprotein A-I.
Connection Strength
0,144
-
Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension Study. JAMA Cardiol. 2017 06 01; 2(6):598-607.
Score: 0,144